Publications
85
Citations
1,941
Est. group size
~6
Recurring co-author estimate
Active years
27
Publishing since 2000
Scott Visovatti's work focuses on pulmonary hypertension (high blood pressure in the lung arteries) and related blood vessel and clotting disorders, including chronic thromboembolic pulmonary hypertension (a form caused by unresolved blood clots) and pulmonary arterial hypertension linked to systemic sclerosis. His research spans clinical care topics such as risk stratification, exercise testing, and balloon angioplasty procedures, as well as more basic studies of clotting proteins and metabolic changes in blood vessel disease. This work is largely clinical and translational, aimed at improving diagnosis, treatment pathways, and quality of life for patients with these vascular lung conditions.
Publication output has fluctuated over the past decade but shows a recent upward trend, with higher output from 2023 to 2025 compared to earlier years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Abstract Th0090: Von Willebrand Factor Inhibition by BB-031 Prevents and Thrombolyses Clots in a Murine Model of Venous Thrombosis
JVS Vascular Science · 2026
- Echocardiographic assessment of elevated pulmonary vascular pressures after resolution of critical illness
medRxiv · 2025
- Abstract TP7: Comparison of inflammatory clot markers in higher and lower shear stress environments: is there really that big of a difference?
Stroke · 2025
- New Treatment Pathways, Drug Development and Clinical Trial Designs: Incorporation of Risk Stratification
Advances in Pulmonary Hypertension · 2025
- Clinical Outcomes After Sonographic Assessment of Pulmonary Vascular Pressures in the Critically Ill
American Journal of Respiratory and Critical Care Medicine · 2025
- Abstract Th0090: Von Willebrand Factor Inhibition by BB-031 Prevents and Thrombolyses Clots in a Murine Model of Venous Thrombosis
Arteriosclerosis Thrombosis and Vascular Biology · 2025
- A Roundtable Discussion Addressing Patient-Centered Care and Quality of Life in Patients With Pulmonary Arterial Hypertension
Advances in Pulmonary Hypertension · 2025
- Pulmonary Embolism Center of Excellence
Cardiac Electrophysiology Clinics · 2025
- Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association
Circulation · 2024
- Aberrant long-chain fatty acid metabolism associated with evolving systemic sclerosis-associated pulmonary arterial hypertension
American Journal of Physiology-Lung Cellular and Molecular Physiology · 2024
- The Invasive Cardiopulmonary Exercise Test
Heart Failure Clinics · 2024
- Exercise Testing in Pulmonary Hypertension and Heart Failure
Heart Failure Clinics · 2024
- A Collaborative, Interinstitutional Program to Improve the Care of Patients With Chronic Thromboembolic Pulmonary Hypertension
CHEST Pulmonary · 2024
- Exercise Training in Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension
Heart Failure Clinics · 2024
- Cardiac MRI Phasic Assessment of Strain in Right Ventricular Dysfunction
medRxiv · 2024
- Heart Failure Clinics×5
- Journal of the American College of Cardiology×5
- Circulation×4
- Journal of the Society for Cardiovascular Angiography & Interventions×4
- Arthritis & Rheumatology×2
- Rebecca Vanderpool
Medicine · The Ohio State University
- Priscilla Correa‐Jaque
Medicine · The Ohio State University
- Ankit A. Desai
Medicine · Indiana University
- Andrea L. Frump
Medicine · Indiana University
- Amanda Fisher
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile